Addiction, Depression, Psychosis, SchizophreniaDiseases of NeglectDrug PoliticsHealthcare PoliticsMedically-Induced Opioid Addiction
Opioid Advertising Worries Continue
CMAJ June 11 2018 Opioid Advertising Worries Remain
-
August 13, 2026 Doctoring AI for Doctors: What’s Next?
Read more -
April 26, 2026 The Global AI Health Data Gold Rush
Read more -
April 25, 2026 Europe Reboots Medical AI
Read more -
November 21, 2025 Canadian vaccination gaps spur measles
Read more -
September 5, 2025 Digital Twins: Clinical trials transformed
Read more -
August 16, 2025 Canada’s “status quo” tobacco settlement
Read more -
May 9, 2025 Trump dumps AI regulations
Read more -
April 15, 2025 Can AI brain implants make us smarter?
Read more -
December 15, 2024 Clinical trials that will reshape medicine in 2025
Read more -
November 27, 2024 Indigenous Consultations: Ontario’s Superhighway Bypass
Read more -
October 18, 2024 Conjuring-up crime data to attack safe drug consumption sites
Read more -
September 27, 2024 Ditching Nature: Ontario’s Superhighway Secrets
Read more -
August 10, 2024 Olympic Sugardaddies Called to Account
Read more -
May 17, 2024 The Lancet: Canada’s Family Physician Shortage
Read more -
May 7, 2024 The future of brain-computer interfaces
Read more -
March 12, 2024 Pocketing medical AI: Nature Medicine March 12 2024
Read more -
February 24, 2024 Canada’s Pharmacare Showdown: The Lancet Feb 24 2024
Read more -
February 17, 2024 Nonstick chemicals come unstuck: The Lancet Feb 17 2024
Read more -
December 7, 2023 STAT Dec 7 2023 – AI and reproductive freedom: The big tech threat
Read more -
December 7, 2023 Clinical trials that will shape 2024: Nature Medicine Dec 7 2023
Read more
Recent Publications
Canada’s federal prisons introduce safe needle solutions
Lancet May 26 2018 Canada Reveals Prison Needle Program
New Drugs for Psychosis & Schizophrenia
The Lancet May 5 2018 FDA Pimavanserin review
Addiction, Depression, Psychosis, SchizophreniaCanadian Science PolicyDrug PoliticsHealthcare Politics
Urgent call for cannabis health research solutions
With the deadline for legalization of nonmedical marijuana approaching, scientists studying the health impacts of cannabis are calling on the federal government to implement a comprehensive research program. “Considerably more …
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaDrug PoliticsHealthcare PoliticsHealthcare Privatization: A Global Business Campaign
Canada considers fairer pharma prices
Spending by Canadian governments on patented drugs costing more than $10 000 per patient annually increased 60% in 2016 . Spending on brand-name pharmaceuticals as a whole rose 18%.
